Abstract
Kawasaki Disease (KD) and Multisystem Inflammatory Syndrome in Children (MIS-C) are not separate entities but different ends of the immune response spectrum. Among the hyperinflammation spectrum, each viral variant induces a distinct MIS-C phenotype, with the Omicron wave resembling KD. Clinical phenotype stratification outperformed MIS-C definitions in identifying patient subgroups, confirming the value of clinical features in managing infection-triggered hyperinflammation. The inverse relationship between pre-pandemic KD incidence and MIS-C reporting supports MIS-C being a SARS-CoV-2-triggered KD, underscoring critical equity and diversity considerations. A pathogen-agnostic approach to post-infectious hyperinflammation would recognize the full spectrum of phenotypes and complications and avoid confusion due to new naming conventions.
Introduction
Since the emergence of the COVID-19 pandemic, the pediatric medical community has grappled with the classification of a severe hyperinflammatory condition known as Multisystem Inflammatory Syndrome in Children (MIS-C). Sharing numerous clinical features with Kawasaki Disease (KD) and toxic shock syndrome, MIS-C sparked a persistent debate: is it a novel clinical entity or a specific manifestation of KD triggered by SARS-CoV-2?
The initial confusion was exacerbated by varying case definitions from international bodies like the World Health Organization (WHO) and the Royal College of Paediatrics and Child Health (RCPCH). These definitions often prioritized the most severe "shock" phenotypes, potentially overlooking the broader spectrum of the disease. Furthermore, significant geographic discrepancies in MIS-C reporting suggested that regional factors might influence how the syndrome is perceived. This study aims to unify these observations by analyzing how viral variants influence clinical presentation and how baseline regional rates of KD affected the "discovery" of MIS-C.
Methodology
Researchers conducted a single-center, prospective observational study at Toronto’s Hospital for Sick Children (SickKids), involving 384 patients treated for MIS-C between March 2020 and September 2023. The study employed several innovative analytical approaches:
- Variant Cohorting: Patients were grouped based on the dominant community variant at the time of their infection: Ancestral/pre-Delta, Delta, and Omicron.
- Phenotype Stratification: Instead of relying solely on international definitions, patients were classified into three clinical phenotypes: shock, KD, and fever with hyperinflammation.
- Statistical Benchmarking: The effectiveness of different classification systems (clinical phenotypes vs. WHO/RCPCH definitions) was compared using empirical cumulative distribution functions (eCDFs) of p-values to determine which system best identified homogenous patient subgroups.
- Regional Modeling: To understand global reporting trends, Gaussian generalized linear models analyzed 50 years of KD incidence data across six countries (Japan, Taiwan, Canada, USA, UK, and Italy), calculating a "signal-to-noise" ratio for MIS-C reporting relative to baseline KD rates.
Results and Discussion
The "Variant Dial" Effect
A primary finding of the study is that the SARS-CoV-2 variant acts as a "dial" for the pediatric immune system. The clinical phenotype of MIS-C shifted significantly depending on the infecting variant. For instance, the Delta variant was more likely to induce the severe "shock" phenotype (35% of cases). Conversely, the Omicron variant shifted the spectrum toward a clinical picture nearly identical to classic KD, with 80% of cases exhibiting the KD phenotype. This shift suggests that MIS-C and KD are not distinct diseases but rather different points on a single spectrum of post-infectious hyperinflammation.
The Signal-to-Noise Phenomenon
The study provides a compelling explanation for why MIS-C was initially identified as a "new" disease primarily in Western countries. In regions like Japan and Taiwan, where baseline KD rates are naturally high, the increase in cases during the pandemic was perceived as being within the expected range of KD fluctuation. In contrast, in countries like the UK, which has a low baseline KD incidence, the same relative increase appeared as a massive, novel "signal." The UK had the highest ratio of COVID-19 infections to KD cases (821.5), while Japan and Taiwan had the lowest, explaining why the latter did not identify MIS-C as a separate entity.
Performance of Clinical Definitions
The analysis of classification systems revealed that standardized surveillance definitions (WHO and RCPCH) were less effective at identifying biologically similar patient groups than simple bedside clinical phenotyping. The eCDF analysis demonstrated that clinical phenotype stratification outperformed international definitions in distinguishing subgroups across 87.5% of tested variables, compared to 70.8% for WHO and only 29.2% for RCPCH definitions. This underscores the value of clinical features over rigid, often restrictive, administrative definitions.
Genetic and Demographic Considerations
The study also noted that children of Asian descent were overrepresented in the MIS-C cohorts, particularly during the Omicron wave. This mirrors pre-pandemic KD trends and reinforces the genetic link between the two conditions, highlighting the importance of equity and diversity in understanding pediatric hyperinflammatory syndromes.
Conclusion
The findings of this study argue for a "pathogen-agnostic" approach to post-infectious hyperinflammation. Rather than creating new nomenclature for every emerging viral trigger, the medical community should focus on the underlying clinical phenotypes to guide management. Recognizing MIS-C as a SARS-CoV-2-triggered manifestation of the KD spectrum allows for more consistent global health strategies and ensures that clinical management is rooted in established knowledge of hyperinflammatory responses. Future work should continue to explore the genetic and environmental factors that determine an individual's position on this inflammatory spectrum.
Summary updated